Mechanism and therapeutic effectiveness of nerve growth factor in osteoarthritis pain

Ther Clin Risk Manag. 2017 Aug 1:13:951-956. doi: 10.2147/TCRM.S139814. eCollection 2017.

Abstract

Osteoarthritis (OA) is the most common form of articular joint arthritis and a cause of significant morbidity. In this review, we present the role of nerve growth factor (NGF) in pain generation, relationship between NGF and OA pain, and pathogenic factors (interleukin-1β, transforming growth factor-β1, mechanical loading, and adipokines) involved in OA development. Since NGF blocking is an efficient way to inhibit OA-associated pain, we summarize four categories of drugs that target NGF/tropomyosin receptor kinase A (TrkA) signaling. In addition, we discuss the future of NGF/TrkA antagonists and underline their potential for use in OA pain relief. A better understanding of the causes and treatment of OA will facilitate the development of more effective methods of OA pain management.

Keywords: TRPV1; TrkA; nerve growth factor; osteoarthritis; pain.

Publication types

  • Review